FDA OKs New Agent to Block Chemotherapy-Induced Neutropenia

The new colony-stimulating factor from China proved comparable to pegfilgrastim (Neulasta) in clinical testing.
MDedge News

source https://www.medscape.com/s/viewarticle/998857?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension

RA and RA-ILD Linked to Higher Lung Cancer Risk

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?